What is JBI's health score?

Janus International Group, Inc. (JBI) has a TradeApes health score of 49 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is JBI's estimated fair value?

Based on our 5-year discounted cash flow model, Janus International Group, Inc.'s estimated fair value is $14.87 per share, representing a 175.3% upside from the current price. This is a model estimate, not a price target or investment recommendation.

Is JBI undervalued or overvalued?

Our model currently rates JBI as Undervalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

Create an account for unlimited access

Janus International Group, Inc. (JBI)

Industrials Undervalued low mixed

$5.4

Updated: 2026-07-18

TradeApes Score

Financial Strength

45 Mixed

Operating Trend

50 Mixed

Relative Value

40 Weak

Capital Allocation

55 Mixed

Risk Management

70 Healthy

Est. Fair Value $14.87

DCF Upside +175.3%

Sector Rank #2165 of 7248

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Historically expensive — EV/EBITDA in top 20% of its 5-year range

Unlock Full Report →

Industry Related Stocks

American Airlines Group Inc. (AAL) Absci Corp (ABSI) Arcosa, Inc. (ACA) Acco Group Holdings Ltd (ACCL) ACCESS Newswire Inc. (ACCS) ACORN ENERGY, INC. (ACFN)

See all Industrials stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.